HKND:NYE-Humankind Benefit Corporation - Humankind US Stock ETF (USD)

ETF | Others |

Last Closing

USD 32.817

Change

+0.03 (+0.08)%

Market Cap

USD 0.15B

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

+0.09 (+0.42%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.15 (+0.26%)

USD 34.45B
DFAC Dimensional U.S. Core Equity 2..

+0.31 (+0.94%)

USD 29.38B
DTB DTE Energy Company 2020 Series

+0.14 (+0.67%)

USD 26.58B
JPST JPMorgan Ultra-Short Income ET..

-0.02 (-0.04%)

USD 25.41B
SGOV iShares® 0-3 Month Treasury B..

+0.01 (+0.01%)

USD 25.27B
GBTC Grayscale Bitcoin Trust (BTC)

+0.63 (+1.37%)

USD 23.75B
AVUV Avantis® U.S. Small Cap Value..

+1.10 (+1.23%)

USD 12.53B
JAAA Janus Detroit Street Trust - J..

+0.02 (+0.04%)

USD 11.98B
DFUV Dimensional US Marketwide Valu..

+0.31 (+0.78%)

USD 10.93B

ETFs Containing HKND

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.16% 70% C- 69% C-
Dividend Return 0.83% 30% F 22% F
Total Return 12.99% 70% C- 65% D
Trailing 12 Months  
Capital Gain 15.30% 63% D 64% D
Dividend Return 0.85% 14% F 10% F
Total Return 16.15% 60% D- 56% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.98% 60% D- 47% F
Dividend Return 2.84% 58% F 41% F
Total Return 0.86% 40% F 19% F
Risk Return Profile  
Volatility (Standard Deviation) 7.20% 63% D 85% B
Risk Adjusted Return 39.51% 60% D- 58% F
Market Capitalization 0.15B 68% D+ 32% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.